What We're Reading: Page 230
Industry reads hand-picked by our editors
Jan 31, 2019
-
CNN
Opioid maker Purdue Pharma fights to prevent documents involving Sackler family from going public
-
The Boston Globe
Charlie Baker takes on big pharma
-
The New York Times
Was C.T.E. stealing his mind? A gunshot provided the answer
-
The Wall Street Journal
Pharma investors, pick your poison
Jan 30, 2019
-
Vantage
Following the M&A money, by phase and therapy area
-
The New York Times
On Both Ends of Capitol, Both Parties Warn Big Pharma on Drug Prices
-
S&P Global Market Intelligence
US FDA back in business after shutdown, but regulatory work has 'piled up'
-
Healthcare Dive
Anthem accelerates launch of PBM IngenioRx
Jan 29, 2019
Jan 28, 2019
-
The New York Times
These Patients Had Sickle-Cell Disease. Experimental Therapies Might Have Cured Them.
-
BioCentury
PhRMA to accept inflation caps
-
The Wall Street Journal
Pfizer Pivots to Cancer Drugs for Growth
-
Bloomberg
Takeda Said to Plan Biggest Japan Bond Sale After Shire Purchase
Jan 25, 2019
-
CBS
Sackler family, known for ties to prestigious institutions, stays quiet on opioid crisis accusations
-
Reuters
Not-for-profit to offer 20 generic drugs in 2019 to alleviate shortages
-
The Guardian
FDA's opioids adviser accuses agency of having 'direct' link to crisis
-
Bloomberg
Big pharma's drug studies are getting a NASA-style makeover
Jan 24, 2019
-
Financial Times
UK biotech doubles investment but offers few IPOs
-
The Guardian
Pharma firms to be incentivised to develop new superbug drugs
-
Nature
Gene therapies in ophthalmic disease
Previous
